Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Renovorx, Inc. (RNXT) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Renovorx, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1574094.
Total stock buying since 2022: $180,509.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $46,316.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 174,145 | $158,083 | 0 | $0 | 20,480 | $3,072 |
| 2024 | 172,128 | $0 | 0 | $0 | 0 | $0 |
| 2023 | 1,100 | $1,151 | 0 | $0 | 0 | $0 |
| 2022 | 10,682 | $21,275 | 0 | $0 | 25,438 | $43,244 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 10,000 | $9,300 | 0 | $0 | 0 | $0 |
| 2025-06 | 21,000 | $29,399 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 20,480 | $3,072 |
| 2025-04 | 143,145 | $119,384 | 0 | $0 | 0 | $0 |
| 2024-01 | 172,128 | $0 | 0 | $0 | 0 | $0 |
| 2023-10 | 1,100 | $1,151 | 0 | $0 | 0 | $0 |
| 2022-11 | 0 | $0 | 0 | $0 | 25,438 | $43,244 |
| 2022-06 | 5,182 | $10,001 | 0 | $0 | 0 | $0 |
| 2022-05 | 5,500 | $11,274 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | Bagai Shaun (Chief Executive Officer) | Buy | 5,000 | .91 | 4,550 |
| 2025-08-22 | Bagai Shaun (Chief Executive Officer) | Buy | 5,000 | .95 | 4,750 |
| 2025-06-05 | Agah Ramtin (Chief Medical Officer) | Buy | 21,000 | 1.40 | 29,399 |
| 2025-05-02 | Marton Laurence | Option Ex | 20,480 | .15 | 3,072 |
| 2025-04-15 | Agah Ramtin (Chief Medical Officer) | Buy | 15,000 | .90 | 13,500 |
| 2025-04-15 | Bagai Shaun (Chief Executive Officer) | Buy | 7,500 | .91 | 6,825 |
| 2025-04-11 | Agah Ramtin (Chief Medical Officer) | Buy | 20,000 | .80 | 16,000 |
| 2025-04-10 | Kocak Ron (VP Controller and PAO) | Buy | 6,500 | .79 | 5,135 |
| 2025-04-09 | Kocak Ron (VP Controller and PAO) | Buy | 6,000 | .80 | 4,800 |
| 2025-04-09 | Agah Ramtin (Chief Medical Officer) | Buy | 30,000 | .81 | 24,390 |
| 2025-04-09 | Bagai Shaun (Chief Executive Officer) | Buy | 10,000 | .83 | 8,300 |
| 2025-04-08 | Kocak Ron (VP Controller and PAO) | Buy | 95 | .80 | 76 |
| 2025-04-08 | Agah Ramtin (Chief Medical Officer) | Buy | 26,000 | .84 | 21,840 |
| 2025-04-08 | Marton Laurence | Buy | 12,050 | .85 | 10,218 |
| 2025-04-07 | Bagai Shaun (Chief Executive Officer) | Buy | 10,000 | .83 | 8,300 |
| 2024-01-26 | Macfarlane K. Angela | Buy | 40,983 | .00 | 0 |
| 2024-01-26 | Agah Ramtin (Chief Medical Officer) | Buy | 40,983 | .00 | 0 |
| 2024-01-26 | Bagai Shaun (Chief Executive Officer) | Buy | 40,983 | .00 | 0 |
| 2024-01-26 | Marton Laurence | Buy | 8,196 | .00 | 0 |
| 2024-01-26 | Spiegel Robert J. | Buy | 40,983 | .00 | 0 |
| 2023-10-03 | Nelms Angela (Chief Operating Officer) | Buy | 1,100 | 1.05 | 1,151 |
| 2022-11-03 | Marton Laurence (Director) | Option Ex | 25,438 | 1.70 | 43,244 |
| 2022-06-07 | Agah Ramtin (Chief Medical Officer) | Buy | 5,182 | 1.93 | 10,001 |
| 2022-05-19 | Bagai Shaun (Chief Executive Officer) | Buy | 5,500 | 2.05 | 11,274 |
Insider trading activities including stock purchases, stock sales, and option exercises of RNXT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Renovorx, Inc. (symbol RNXT, CIK number 1574094) see the Securities and Exchange Commission (SEC) website.